Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Northwest Biotherapeutics (NWBO) Asset Utilization Ratio: 2009-2025

Historic Asset Utilization Ratio for Northwest Biotherapeutics (NWBO) over the last 17 years, with Sep 2025 value amounting to 0.03.

  • Northwest Biotherapeutics' Asset Utilization Ratio fell 43.84% to 0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03, marking a year-over-year decrease of 43.84%. This contributed to the annual value of 0.05 for FY2024, which is 22.45% down from last year.
  • Per Northwest Biotherapeutics' latest filing, its Asset Utilization Ratio stood at 0.03 for Q3 2025, which was down 18.77% from 0.04 recorded in Q2 2025.
  • Northwest Biotherapeutics' 5-year Asset Utilization Ratio high stood at 0.07 for Q3 2023, and its period low was -0.00 during Q4 2021.
  • Over the past 3 years, Northwest Biotherapeutics' median Asset Utilization Ratio value was 0.06 (recorded in 2024), while the average stood at 0.05.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first crashed by 110.08% in 2021, then skyrocketed by 14,793.03% in 2023.
  • Northwest Biotherapeutics' Asset Utilization Ratio (Quarterly) stood at -0.00 in 2021, then spiked by 1,345.74% to 0.05 in 2022, then climbed by 20.72% to 0.07 in 2023, then decreased by 24.25% to 0.05 in 2024, then slumped by 43.84% to 0.03 in 2025.
  • Its last three reported values are 0.03 in Q3 2025, 0.04 for Q2 2025, and 0.05 during Q1 2025.